These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19519370)

  • 1. The important new drug target in cardiovascular medicine--the vascular glycocalyx.
    Drake-Holland AJ; Noble MI
    Cardiovasc Hematol Disord Drug Targets; 2009 Jun; 9(2):118-23. PubMed ID: 19519370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the important new drug target in cardiovascular medicine - the vascular glycocalyx.
    Drake-Holland AJ; Noble MI
    Cardiovasc Hematol Disord Drug Targets; 2012 Sep; 12(1):76-81. PubMed ID: 22746343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasculoprotective properties of the endothelial glycocalyx: effects of fluid shear stress.
    Gouverneur M; Berg B; Nieuwdorp M; Stroes E; Vink H
    J Intern Med; 2006 Apr; 259(4):393-400. PubMed ID: 16594907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endothelial glycocalyx: a review of the vascular barrier.
    Alphonsus CS; Rodseth RN
    Anaesthesia; 2014 Jul; 69(7):777-84. PubMed ID: 24773303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Medical significance of endothelial glycocalyx. Part 2: Its role in vascular diseases and in diabetic complications].
    Frati Munari AC
    Arch Cardiol Mex; 2014; 84(2):110-6. PubMed ID: 24836779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothesis: arterial glycocalyx dysfunction is the first step in the atherothrombotic process.
    Noble MI; Drake-Holland AJ; Vink H
    QJM; 2008 Jul; 101(7):513-8. PubMed ID: 18319293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects.
    Masola V; Zaza G; Onisto M; Lupo A; Gambaro G
    Int Angiol; 2014 Jun; 33(3):243-54. PubMed ID: 24936533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The endothelial glycocalyx: a potential barrier between health and vascular disease.
    Nieuwdorp M; Meuwese MC; Vink H; Hoekstra JB; Kastelein JJ; Stroes ES
    Curr Opin Lipidol; 2005 Oct; 16(5):507-11. PubMed ID: 16148534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycocalyx in Atherosclerosis-Relevant Endothelium Function and as a Therapeutic Target.
    Mitra R; O'Neil GL; Harding IC; Cheng MJ; Mensah SA; Ebong EE
    Curr Atheroscler Rep; 2017 Nov; 19(12):63. PubMed ID: 29127504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the endothelial glycocalyx in advanced age and cardiovascular disease.
    Machin DR; Phuong TT; Donato AJ
    Curr Opin Pharmacol; 2019 Apr; 45():66-71. PubMed ID: 31112922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow-dependent concentration polarization and the endothelial glycocalyx layer: multi-scale aspects of arterial mass transport and their implications for atherosclerosis.
    Vincent PE; Weinberg PD
    Biomech Model Mechanobiol; 2014 Apr; 13(2):313-26. PubMed ID: 23836008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The glycocalyx and cardiovascular disease in diabetes: should we judge the endothelium by its cover?
    Lemkes BA; Nieuwdorp M; Hoekstra JB; Holleman F
    Diabetes Technol Ther; 2012 Jun; 14 Suppl 1():S3-10. PubMed ID: 22650222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptors 2 and 4 mediate hyperglycemia induced macrovascular aortic endothelial cell inflammation and perturbation of the endothelial glycocalyx.
    Pahwa R; Nallasamy P; Jialal I
    J Diabetes Complications; 2016; 30(4):563-72. PubMed ID: 26908090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Criteria for evaluating arterial endothelial dysfunction and modes of its correction: a review of literature].
    Pushkareva TA; Koriakina LB; Runovich AA; Kuril'skaia TE; Pivovarov IuI
    Klin Lab Diagn; 2008 May; (5):3-7. PubMed ID: 18592641
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeting hyaluronan of the endothelial glycocalyx for therapeutic intervention.
    Wheeler-Jones CP; Farrar CE; Pitsillides AA
    Curr Opin Investig Drugs; 2010 Sep; 11(9):997-1006. PubMed ID: 20730694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycocalyx and endothelial (dys) function: from mice to men.
    van den Berg BM; Nieuwdorp M; Stroes ES; Vink H
    Pharmacol Rep; 2006; 58 Suppl():75-80. PubMed ID: 17332675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the endothelial glycocalyx layer on arterial LDL transport under normal and high pressure.
    Liu X; Fan Y; Deng X
    J Theor Biol; 2011 Aug; 283(1):71-81. PubMed ID: 21645523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in perfused boundary region of endothelial glycocalyx is associated with higher prevalence of ischemic heart disease and lesions of microcirculation and vascular wall.
    Gorshkov AY; Klimushina MV; Boytsov SA; Kots AY; Gumanova NG
    Microcirculation; 2018 May; 25(4):e12454. PubMed ID: 29608790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemic preconditioning and superoxide dismutase protect against endothelial dysfunction and endothelium glycocalyx disruption in the postischemic guinea-pig hearts.
    Beresewicz A; Czarnowska E; Maczewski M
    Mol Cell Biochem; 1998 Sep; 186(1-2):87-97. PubMed ID: 9774189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial glycocalyx as potential diagnostic and therapeutic target in cardiovascular disease.
    Broekhuizen LN; Mooij HL; Kastelein JJ; Stroes ES; Vink H; Nieuwdorp M
    Curr Opin Lipidol; 2009 Feb; 20(1):57-62. PubMed ID: 19106708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.